home logo active marketing logo

Call Us Today: 1 (888) 251-4635

Top Healthcare Marketing Agencies for Admissions Growth

Table of Contents
Ready to See Results?

From strategy to execution, we turn underperforming campaigns into measurable wins. Let’s put our expertise to work for your business.

Contact Us

Key Takeaways

  • Standard agency roundups rank vendors by capabilities rather than admissions math, which is why CMOs need a framework built around the six levers that actually move census.
  • Intake capacity sets the ceiling on marketing ROI, and OIG found 45% of surveyed behavioral health providers were unavailable to new Medicare and Medicaid patients 16.
  • HIPAA-compliant acquisition requires documented Business Associate Agreements, authorization language, and pixel configurations, because marketing uses of PHI generally require written authorization 1, 2.
  • FTC-substantiated claims handling matters because testimonials carry the same substantiation burden as the advertiser’s own claims, and consumer stories alone are not competent scientific evidence 6, 7.
  • Reputation infrastructure shifts provider selection, since negative reviews reduce consumer intent to choose and substantive responses measurably soften that impact 21, 24.
  • Access and intake alignment turns calls into admits by tracking speed to answer, VOB turnaround, and stage-to-stage timing against the caller’s decision window 14, 15.
  • Referral and navigator integration captures admit volume from SAMHSA’s helpline and payer navigator programs that route members to in-network providers 19, 20.
  • Attribution should terminate at the payer-adjusted admit rather than the lead, with cost per admit segmented by campaign, payer, and level of care.
  • Agency archetypes each score differently across the six criteria, so CMOs typically assemble a stack matched to where the center is weakest rather than betting on one partner.
  • Multi-state portfolios need per-site scorecards on the five CAHPS dimensions, with local reputation and intake alignment managed per facility while creative and compliance stay centralized 15.

Why the standard agency roundup fails behavioral health CMOs

Most “top healthcare marketing agencies” lists rank vendors by capabilities checklists, award counts, or Clutch stars. None of those signals predict what a CMO at an addiction treatment center actually needs to see next quarter: verified benefit-eligible calls, a lower cost per admit, and a payer mix that holds up under operator review.

Behavioral health marketing runs inside a narrow regulatory corridor. HHS defines most patient-directed promotional communication as marketing under HIPAA, which triggers written authorization requirements before protected health information can be used for outreach, retargeting, or vendor-driven campaigns 1, 2. The FTC layers a second constraint on top: any objective claim about outcomes, recovery rates, or program effectiveness needs competent substantiation, and testimonials carry the same substantiation burden as the advertiser’s own claims 6, 7. A generalist agency that treats treatment centers like e-commerce brands will produce campaigns that convert well in analytics dashboards and poorly in a compliance review.

The deeper problem with the roundup format is that it rewards capability breadth over admissions math. A CMO managing a P&L does not need a list. She needs a framework that separates agencies by how they perform against the six levers that actually move census:

  • compliant acquisition,
  • substantiated claims handling,
  • reputation infrastructure,
  • access and intake alignment,
  • referral-network integration, and
  • attribution tied to admits rather than form fills.

The rest of this article builds that framework and scores the agency archetypes CMOs are choosing between.

The operational ceiling that caps every marketing dollar

A CMO can double qualified call volume and still miss census targets if the intake queue cannot absorb the demand. That is not a hypothetical. In its 2025 survey of behavioral health providers accepting new Medicare and Medicaid patients, the HHS Office of Inspector General found that 45% of surveyed providers were not available to treat new patients in those programs at all, and among providers who were available, roughly a quarter reported appointment waits longer than 30 days 16. The scope matters: OIG surveyed behavioral health providers listed as in-network for Medicare Advantage, Medicaid managed care, and traditional Medicare, and measured whether those listed providers could actually schedule a new patient. The finding is about a specific payer-mix segment, not the entire behavioral health market, but it defines the shape of the access problem any admissions strategy runs into.

For a treatment center CMO, the implication is direct. Every incremental dollar spent on paid search, SEO, or digital PR is priced against the intake team’s ability to answer, verify benefits, and place the caller into a bed or session within a window the caller will actually wait. When wait times stretch past a few days, calls stop converting to admits. They convert to competitors.

Infographic showing Percentage of surveyed behavioral health providers unavailable for new Medicare/Medicaid patients
Percentage of surveyed behavioral health providers unavailable for new Medicare/Medicaid patients

Six admissions-growth criteria to evaluate any agency

The evaluation criteria below are not a capabilities menu. They are the six places where behavioral health marketing either produces admits or produces cost. A CMO reviewing a current agency or scoping a new one should be able to pull artifacts against each criterion — a HIPAA authorization workflow, a claims substantiation file, a review-response cadence, an intake service-level agreement, a referral pipeline, and an admit-level attribution model. Absence of an artifact is a finding.

HIPAA-compliant acquisition: where authorization begins and ends

The HIPAA marketing rule draws a specific line: a communication that encourages someone to purchase or use a product or service is marketing, and marketing uses of protected health information generally require written authorization from the individual 1, 2. Treatment and care-coordination communications sit in a carve-out — a discharge follow-up call, a referral to another provider, or a message about a case manager’s next step is not marketing under the Privacy Rule 3. The distinction matters because it defines what an agency can and cannot do with a lead list, an EHR export, a website form submission, or a call transcript.

A CMO should be able to answer three questions about any agency handling paid media, lead gen, or CRM work:

  1. What data flows into ad platforms, and does any of it constitute PHI as defined by the covered entity’s Notice of Privacy Practices?
  2. Where in the funnel does the agency rely on authorization, and is the authorization language on file OCR-defensible 2?
  3. When a third-party vendor — a call center, an SMS platform, a retargeting pixel — receives PHI in exchange for remuneration, has that vendor been treated as a marketing partner under the Privacy Rule and papered accordingly 2, 4?

An agency that answers with confidence names its Business Associate Agreements, its pixel and tag-management policy, its conversion API configuration, and the specific fields it strips before data leaves the covered entity’s environment. An agency that answers with slogans about being “HIPAA-aware” is a liability. HHS materials for consumers reinforce the point from the patient side: without authorization, a provider generally cannot use or share information for marketing or advertising 5, and reputational damage from a breach in behavioral health outweighs almost any acquisition gain that produced it.

FTC-substantiated claims: the testimonial liability most agencies miss

Behavioral health marketing runs on stories. Recovery narratives, staff bios, alumni videos, and outcomes copy are the raw material of most treatment center websites and paid campaigns. The FTC treats every objective claim in those materials as subject to substantiation, and it treats testimonials as making the same claims the advertiser would make directly 6, 7.

That has three operational consequences an agency should already be handling:

  • A claim about program effectiveness — completion rates, sobriety timelines, readmission reductions — requires competent and reliable scientific evidence on file before it runs, not after a regulator asks 7.
  • A patient testimonial that describes a specific outcome triggers the same substantiation requirement as if the center had made the claim in its own voice, and consumer testimonials on their own are not competent and reliable scientific evidence 7, 9.
  • Endorsements must reflect the honest opinion or experience of the endorser, and any material connection — payment, free treatment, employment, family relationship to staff — must be disclosed 8.

A CMO evaluating an agency should ask to see the claims substantiation file. Every outcome claim, star rating, “leading provider” superlative, and alumni quote in current creative should map to a source document the agency can produce. If the file does not exist, the agency has been building FTC exposure into the ad account.

The practical implication is that testimonial-heavy campaigns common in the sector need a rewrite, not a disclosure line. Rewriting claims around what a program does — modalities offered, credentialing, average length of stay, in-network payer relationships — is defensible. Marketing an unrepresentative recovery story as a typical result is not 6, 9.

Reputation and review infrastructure as a selection signal

Online reviews are not a vanity metric in this sector. A peer-reviewed study on physician selection found that negative reviews reduced consumers’ intention to choose a provider, and that a physician’s response to those reviews measurably lowered the negative impact 21. A separate systematic review of 63 studies documented consistent patterns in how patients discuss provider quality online and how those discussions shape choice 24. Consumers weigh both commercial ratings and clinical ratings when selecting a physician, and their trust in the source of the rating changes which one dominates the decision 22.

For treatment centers, that translates to a specific agency requirement. The reputation function should include a response protocol with defined turnaround times, escalation paths for reviews describing clinical events, and a HIPAA-compliant response template that does not confirm or deny that the reviewer was a patient. It should include a monitoring surface across Google, Yelp, Facebook, and health-specific directories, and a review-generation workflow that solicits feedback from alumni through channels that do not violate the marketing authorization requirements discussed above.

The 2025 systematic review on trust in digital healthcare adds a broader signal. Consumer trust in digital touchpoints is shaped by human interaction, privacy concerns, data accuracy, digital literacy, and the perceived quality of the intervention 25. A review response written like a legal disclaimer damages trust. A response that acknowledges concern, offers a direct contact for the reviewer, and demonstrates the center’s clinical seriousness supports it. Agencies that treat review response as a template task rather than a clinical-adjacent function are underinvesting the criterion.

Access and intake alignment: converting calls into VOB-eligible admits

AHRQ identifies timely appointments, easy access to information, and good communication as the patient-valued dimensions of care 14. Those dimensions map directly to intake performance: speed to answer, verification of benefits turnaround, clinical assessment scheduling, and the caller’s ability to understand what happens next. The CAHPS Clinician & Group Survey measures the same dimensions — timely appointments, provider communication, care coordination, staff courtesy, and provider rating — and treats them as the observable surface of care quality 15.

An agency aligned to admissions rather than lead volume treats intake as part of the campaign. That includes call routing by service line and payer, hold-time and abandonment monitoring, VOB turnaround targets that match the caller’s decision window, and shared reporting between marketing and admissions on the calls that never became admits and why. Where the intake team cannot absorb paid-media demand within 24 to 48 hours, the agency should be recommending pacing changes, waitlist workflows, or level-of-care referrals rather than defending impression volume.

A CMO can test alignment quickly. Ask the agency for last month’s report of calls that reached the queue, calls that reached VOB, calls that reached admit, and the median time between each stage by campaign and payer. An agency that cannot produce that view is optimizing form fills.

Referral and navigator integration across the care pathway

Admissions do not arrive only through paid search. SAMHSA’s National Helpline runs a free, confidential, 24/7 treatment referral and information service that routes callers toward treatment options 19. Health insurers are increasingly deploying behavioral health navigation services that help members identify needs, choose treatment options, and connect with in-network providers 20. Both are demand channels a treatment center’s marketing function needs to plug into rather than around.

An agency evaluating the referral surface should be mapping payer navigator programs the center participates in, verifying that the center’s listing details across insurer directories match what appears on the website and Google Business Profile, and building content that answers the questions a navigator or helpline referral will ask on behalf of the caller — level of care, admission criteria, insurance accepted, average length of stay, and next-available start dates. SAMHSA’s TEDS data on state-reported admissions and discharges provides a baseline for understanding how admissions flow through the treatment system in each state 18, which shapes where referral partnerships and directory investments produce the highest yield.

Agencies that treat referral traffic as an unattributable rounding error miss where meaningful admit volume actually enters the funnel.

Attribution that ties spend to admission, not to lead

The final criterion is the one that most cleanly separates agencies aligned to admissions from agencies aligned to their own reporting dashboards. Attribution should terminate at the admit and, ideally, at the payer-adjusted admit, not at the form submission or the tracked call.

That requires the agency to work backward from the center’s admissions data. Every marketing-sourced call needs a unique identifier that persists through the intake system and the EHR admission record. Cost per admit needs to be reported by campaign, payer, and level of care, because a self-pay residential admit and a Medicaid outpatient admit are not the same unit of margin. Where privacy considerations prevent moving admission data into ad platforms, offline conversion imports with hashed identifiers or aggregated cohort feedback loops keep bidding aligned to admits without exporting PHI 1, 2.

An agency that reports on cost per lead but resists building a cost-per-admit model is protecting its numbers, not the center’s.

Process infographic summarizing the six evaluation criteria that structure the entire framework section, giving the reader a scannable overview of the operating model

Evidence-Based Strategies from Leading Healthcare Marketing Agencies

See how advanced digital marketing solutions drive measurable admissions growth for behavioral health organizations, using data-driven tactics proven to increase qualified calls.

See the Data

Agency archetypes scored against the six criteria

No single agency archetype scores high across all six admissions-growth criteria. That is the honest read of the market, and it is why most treatment center CMOs end up assembling a stack rather than betting the P&L on a single partner. The five archetypes below cover the choices that actually appear in RFPs and roster reviews.

The behavioral-health specialist.
A shop that works only or primarily in addiction treatment and mental health typically scores high on HIPAA-compliant acquisition and substantiated claims handling because those constraints are baked into every workflow it runs 1, 6. It usually scores high on referral and navigator integration, because it already knows how payer navigator programs and helpline routing shape volume 20. Its weakness tends to be scale of paid-media buying power and, in smaller specialist firms, the depth of engineering support for admit-level attribution.
The full-service healthcare generalist.
A large healthcare agency serving hospitals, health systems, and payers brings mature compliance infrastructure and reputation tooling, and scores high on reputation and review infrastructure because it has built for hospital systems where ratings drive selection 22. Access and intake alignment is the recurring soft spot. Behavioral health intake operates on tighter windows than elective service lines, and generalists often import service-line playbooks that miss the OIG-documented access pressure on new-patient scheduling 16.
The performance/PPC shop.
Independent of vertical, these agencies score high on paid acquisition mechanics and attribution engineering. They tend to score medium at best on HIPAA-compliant acquisition, because conversion API configurations and audience-building practices designed for retail carry PHI risk in a covered-entity environment 1. Substantiated claims handling and reputation infrastructure often sit outside their scope entirely.
The reputation/PR specialist.
Digital PR and reputation firms score high on the review-infrastructure criterion and can defensibly handle FTC endorsement disclosures on earned coverage and alumni content 8. They rarely own acquisition or attribution, and their integration with intake operations is typically indirect.
In-house augmentation.
A lean internal team supported by fractional specialists scores highest on intake alignment and admit-level attribution, because those functions sit inside the operator. It scores lower on execution capacity across the other four criteria unless staffed generously.

The practical read: match archetypes to the criteria where the center is weakest today, not to a capabilities pitch. A center with strong intake but weak reputation infrastructure buys differently than one with strong paid media but no substantiation file.

Infographic showing Percentage of available behavioral health providers with waits longer than 30 days
Percentage of available behavioral health providers with waits longer than 30 days

If you manage a portfolio of facilities across states

A quick scope shift: the framework above assumes a single P&L. For CMOs running a multi-state portfolio — a residential flagship in Florida, IOP sites in Texas, an outpatient network in the Midwest — the six criteria still hold, but the execution surface multiplies by facility. Two levers change the most: local search infrastructure and per-site experience signals.

The AHRQ Clinician & Group Survey measures the same five dimensions at every site a portfolio operates: timely appointments, provider communication, care coordination, staff courtesy, and provider rating 15. Those dimensions map cleanly onto per-site marketing signals a portfolio CMO can actually manage at scale. Timely appointments show up in the Google Business Profile as the “accepts new patients” flag, hours accuracy, and average response time to Google-sourced calls. Provider communication and staff courtesy surface in review sentiment and the response cadence on each location’s profile. Care coordination shows up in how each site’s landing page describes step-downs, alumni programs, and referrals to sibling facilities. Provider rating is the composite the portfolio inherits across Google, Yelp, and health directories.

A portfolio agency that treats every site the same undercuts the strongest properties and fails to lift the weakest. The operational read is a per-site scorecard on the five CAHPS dimensions, refreshed monthly, with local SEO and profile work prioritized where the experience signal is measurably behind. Central creative and compliance stay consolidated; local reputation, listings, and intake alignment stay per site.

A CMO scorecard for current and prospective agencies

The scorecard below is meant to be applied in a working session, not filed. A CMO should be able to score a current agency against it in 90 minutes, using artifacts already in the account, and use the same instrument on any prospective partner responding to an RFP.

Compliant acquisition.
Ask for the Business Associate Agreement inventory, the pixel and conversion API configuration, the list of fields stripped before data leaves the covered entity environment, and the authorization language used when PHI enters marketing workflows 1, 2. Score high if artifacts exist and match the Notice of Privacy Practices. Score low if the answer is verbal.
Substantiated claims.
Request the claims substantiation file. Every outcome number, superlative, and alumni quote in live creative should map to a source document 6, 7. Endorsement disclosures and material-connection statements should be visible in the ads themselves 8. No file, no score.
Reputation infrastructure.
Pull the last 90 days of review responses across Google, Yelp, and health directories. Measure median response time, the share of negative reviews that received a substantive reply, and whether replies avoid confirming patient status 21, 24.
Access and intake alignment.
Request the funnel report from tracked call to VOB to admit, segmented by campaign and payer, with median stage-to-stage time 14, 15. An agency without this view is not scoring the outcome the P&L is measured on.
Referral and navigator integration.
Confirm accurate directory listings across payer navigator programs and alignment between website, Google Business Profile, and insurer directories 20. Ask which SAMHSA-facing and helpline-adjacent surfaces the center is discoverable on 19.
Attribution to admit.
The final row is binary. Cost per admit by campaign, payer, and level of care exists, or it does not.

A behavioral-health specialist that scores the top row honestly, ships a claims file on request, and reports cost per admit is the shortest path from the current roster to a defensible admissions program. Active Marketing sits in that archetype for CMOs assembling the stack described above.

Frequently Asked Questions

What distinguishes a behavioral health marketing specialist from a full-service healthcare generalist?

A specialist builds workflows around HIPAA marketing carve-outs, FTC substantiation for outcome claims, and referral pathways specific to addiction treatment and mental health 1, 6, 20. A generalist brings deeper media buying scale and hospital-grade reputation tooling but often imports service-line playbooks that miss behavioral health intake windows and payer-navigator dynamics. The trade-off is depth of compliance and referral fluency versus breadth of execution capacity.

Can an agency use patient testimonials and success stories in treatment center advertising?

Only with substantiation and disclosure. The FTC treats testimonial claims as if the advertiser made them directly, and consumer testimonials on their own are not competent and reliable scientific evidence for outcome claims 7. Endorsements must reflect the endorser’s honest experience, and material connections such as payment or free treatment must be disclosed 8. Unrepresentative recovery stories marketed as typical results create direct FTC exposure 9.

How should a CMO evaluate whether an agency understands HIPAA marketing rules?

Request specific artifacts: the Business Associate Agreement inventory, the authorization language used when PHI enters marketing workflows, the pixel and conversion API configuration, and the list of fields stripped before data leaves the covered entity environment 1, 2. Ask how the agency distinguishes treatment and care-coordination communications from marketing under the Privacy Rule 3. Verbal reassurance without documented workflows indicates the agency has not internalized the authorization requirement 4.

Why does intake capacity matter when selecting a marketing agency?

Marketing ROI is capped by the intake queue’s ability to answer, verify benefits, and place callers within their decision window. AHRQ identifies timely appointments, access to information, and communication as the patient-valued dimensions of care 14, and the CAHPS Clinician & Group Survey measures those same dimensions as observable quality 15. An agency that never asks about speed to answer, VOB turnaround, or bed availability is optimizing form fills rather than admits.

What attribution model should an agency use for admissions marketing?

Attribution should terminate at the payer-adjusted admit, not the form fill or tracked call. Every marketing-sourced call needs a unique identifier that persists through intake and the EHR admission record, with cost per admit reported by campaign, payer, and level of care. Where PHI cannot move into ad platforms, offline conversion imports with hashed identifiers or aggregated cohort feedback loops keep bidding aligned to admits without exporting protected data 1, 2.

How do online reviews and reputation infrastructure factor into agency selection?

Reviews measurably shift provider selection. Negative reviews reduce consumers’ intention to choose a provider, and substantive physician responses lower that impact 21. A systematic review of 63 studies documents consistent patterns in how patients discuss provider quality online 24, and consumer trust in digital touchpoints is shaped by human interaction, privacy handling, and data accuracy 25. Agencies without a defined response protocol, escalation path, and monitoring surface are underinvesting the criterion.

References

  1. Marketing | HHS.gov. https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/marketing/index.html
  2. MARKETING [45 CFR 164.501, 164.508(a)(3)] Background. https://www.hhs.gov/sites/default/files/ocr/privacy/hipaa/understanding/coveredentities/marketing.pdf
  3. Standards for Privacy of Individually Identifiable Health Information. https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/standards-privacy-individually-identifiable-health-information/index.html
  4. Marketing | HHS.gov. https://www.hhs.gov/hipaa/for-professionals/faq/marketing/index.html
  5. Your Rights Under HIPAA. https://www.hhs.gov/hipaa/for-individuals/guidance-materials-for-consumers/index.html
  6. Health Claims – Federal Trade Commission. https://www.ftc.gov/business-guidance/advertising-marketing/health-claims
  7. Health Products Compliance Guidance. https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance
  8. Guides Concerning the Use of Endorsements and Testimonials in Advertising. https://www.ftc.gov/sites/default/files/attachments/press-releases/ftc-publishes-final-guides-governing-endorsements-testimonials/091005revisedendorsementguides.pdf
  9. 5 principles to help keep your health claims healthy. https://www.ftc.gov/business-guidance/blog/2015/12/5-principles-help-keep-your-health-claims-healthy
  10. Hospital CAHPS (HCAHPS). https://www.cms.gov/data-research/research/consumer-assessment-healthcare-providers-systems/hospital-cahps-hcahps
  11. HCAHPS: Patients’ Perspectives of Care Survey. https://www.cms.gov/medicare/quality/initiatives/hospital-quality-initiative/hcahps-patients-perspectives-care-survey
  12. Consumer Assessment of Healthcare Providers & Systems (CAHPS) Program. https://www.cms.gov/data-research/research/consumer-assessment-healthcare-providers-systems
  13. Consumer Assessment of Healthcare Providers and Systems (CAHPS). https://www.ahrq.gov/cahps/index.html
  14. Topic: Patient Experience. https://www.ahrq.gov/topics/patient-experience.html
  15. CAHPS Clinician & Group Survey. https://www.ahrq.gov/cahps/surveys-guidance/cg/index.html
  16. Availability of Surveyed Behavioral Health Providers to Treat New Patients Enrolled in Medicare and Medicaid. https://oig.hhs.gov/reports/all/2025/availability-of-surveyed-behavioral-health-providers-to-treat-new-patients-enrolled-in-medicare-and-medicaid/
  17. 2024 Data on Substance Use and Mental Health Treatment Facilities. https://www.samhsa.gov/data/report/2024-n-sumhss-annual-report
  18. Key Resources and Tools for TEDS. https://www.samhsa.gov/data/data-we-collect/teds-treatment-episode-data-set
  19. National Helpline for Mental Health, Drug, Alcohol Issues. https://www.samhsa.gov/find-help/helplines/national-helpline
  20. Behavioral Health Navigation Services Offered by Health Insurers. https://aspe.hhs.gov/reports/bh-navigators-report-authors
  21. Effect of Negative Online Reviews and Physician Responses …. https://pmc.ncbi.nlm.nih.gov/articles/PMC10966444/
  22. How Online Quality Ratings Influence Patients’ Choice of Physicians. https://pmc.ncbi.nlm.nih.gov/articles/PMC5891665/
  23. Association Between Medicare Summary Star Ratings for Patient Experience and Clinical Outcomes. https://pmc.ncbi.nlm.nih.gov/articles/PMC5513621/
  24. What Do Patients Say About Doctors Online? A Systematic Review of Studies on Patient Online Reviews. https://pubmed.ncbi.nlm.nih.gov/30958276/
  25. A systematic review of consumers’ and healthcare professionals’ trust in digital healthcare. https://pubmed.ncbi.nlm.nih.gov/39984678/